Moreover, reduced CXCL12-mediated signals may be able to induce the egress of CML cells, particularly LSCs, to extra-bone marrow sites, thereby promoting CML progression. Here, CXCL12 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.